Hep C - Migenix: infectious ambitions in hepatitis

Migenix: infectious ambitions in hepatitis
Pharmaceutical Business Review - Jan 25 6:07 PM
Migenix has confirmed plans to initiate a viral kinetics study with celgosivir in hepatitis C.Save to My Web

Biologic shows promise in severe Crohn's disease
Medical Post Online - Feb 20 7:32 PM
The monoclonal antibody Remicade (infliximab) is now indicated for treatment of fistulizing Crohn's disease in adults who have responded inadequately to conventional treatment.Save to My Web

Idenix and Novartis Seek European Approval of Telbivudine for the Treatment of Patients with Chronic Hepatitis B
[Press Release] PR Newswire via Yahoo! Finance - Feb 07 5:00 AM
Idenix Pharmaceuticals, Inc. and Novartis announced today the submission of a Marketing Authorization Application to the European Medicines Agency seeking marketing authorization for the 600 mg dose of telbivudine for the treatment of chronic hepatitis B.Save to My Web

YOU ARE HERE:
Aidsmap - Jan 26 4:13 AM
Using liver biopsies the researchers established that 25% of patients with normal alanine aminotransferase (ALT) levels - a key marker of liver function have such severe liver damage that they require anti-hepatitis C treatment, with 13% having cirrhosis, permanent scarring of the liver.Save to My Web

euro adhoc: Intercell AG / other / Intercell's Hepatitis C vaccine meets success criteria for further development -
vwd.de - Jan 31 9:18 AM
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement.Save to My Web